L7, Epigenetics Flashcards

1
Q

Characteristics of Angelmann syndrome: (Symptoms)

A
  • Developmental delay
  • Severe speech impairment
  • Jerky movements and hand flapping
  • Happy disposition
  • Microcephaly (small head)
  • Seizures, abnormal EEG (electrical activity in brain measured using electrodes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Prader Willi characteristics:

A
  • Hypotonia
  • Poor suckling reflex in infancy vs insatiable appetite in later life
  • Obesity and short stature
  • Compulsive behaviour like skin picking
  • Strabismus (eye crossing)
  • Hypogonadism, poor sexual development
  • Lower than normal level of growth hormone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Deletion in PWS and AS: Origin, cause and detection

A
  • Around 75% of PWS and AS cases originate in a deletion of up to 6 Mbp on chromosome 15q11.2q13.1
  • -> Deletions are either break point 1 to 3 (type I) or 2 to 3 (type II)
  • Deletion can occur as a result of aberrant meiotic recombination between direct repeats that flank the region
  • Deletion can be detected by FISH or array CGH for diagnoses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is genomic imprinting carried out under normal circumstances?

A
  • Imprinting centre (IC) coordinates the expression of certain genes on exclusively paternal or maternal chromosome
  • IC is methylated on maternal chromosome
  • Normally, an individual will thus inherit one intact maternal and one intact paternal chromosome 15
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Effect of genomic imprinting under Chr 15 deletions:

A
  • Paternal deletion -> PWS (One or more of genes normally expressed on parental chr. are turned off in maternal)
  • Maternal deletion -> AS (Converse situation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is genomic imprinting an epigenetic trait?

A
  • Stably heritable phenotype, no change to DNA sequence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Molecular basis for genomic imprinting:

A
  • Methylation of cytosine bases at CpG sites in differentially methlyated regions (DMRs) is responsible for imprinting (carried out by DNMTs) -> maintenance methyltransferase recognises hemi-meth. sites -> full methylation
  • Either maternal or paternal allele is methylated in embryo and somatic cells
  • As such, all oocytes in next generation have maternal pattern and vice versa for sperm
  • Imprint is erased in subsequent germ cells of following generation (primordial germ cells of offspring)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Maternal transcript in 15q11-13

(Effect on transcription of particular genes)

A
  1. Imprinting centre is methylated
  2. Methlyation of IC blocks transcription of PWS genes flanking IC site (heterochromatic)
  3. ATP10A and UBE3A genes remain active
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Loss of snoRNA expression in PWS:

A
  • Studies of PWS patients implicate disruption of SNORD 116 cluster of snoRNAs (small nucleolar)
  • snoRNAs are located in introns of SNHG14, ubiquitously expressed, normally highest expression levels and longest transcripts in brain
  • Function in maturation of rRNA for ribosome assembly and in regulation of mRNA levels and splicing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chromosome 15 (paternal) methylation status effect on gene expression in non-neurons:

A
  1. IC unmethylated
  2. Gene expression activated
  3. SNHG14 transcript terminates after SNORD116 locus in no-neurons
  4. UBE3A gene expressed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Chromosome 15 (paternal) methylation status effect on gene expression in neurons:

A
  1. IC unmethylated
  2. Gene expression activated
  3. SNHG14 transcript extends through SNORD115 to generate antisense transcript to UBE3A
  4. UBE3A expression silenced
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Loss of UBE3A in neurons:

A
  • 11% of AS cases caused by point mutations in maternal UBE3A allele
  • Rest are either uniparental disomy or normal 14q11.2-13.1 deletion
  • E3 ubiquitin ligase; targets proteins for proteasomal degradation -> may target ephexin 5
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Uniparental disomy:

A
  • Both members of a chromosome pair are inherited from one parent, and the other parent’s chromosome for that pair is missing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Uniparental disomy in PWS and AS:

Prevalence and diagnosis

A
  • 25% of PWS cases, ~7%
  • Equivalent to deletion of the paternal or maternal chromosome
  • Array CGH and FISH will be normal -> diagnosis must be confirmed by methylation specific PCR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Methylation specific PCR:

A
  • Bisulfite treatment
  • Defining methylation status of IC
  • Sodium bisulfite treatment to purified genomic DNA -> methylated sequence protects cytosine residues from deamination whereas unmethylated residues are deaminated to uracil
  • PCR amplification carried out from these templates; complementary to different primers (different sizes)
  • Only definitive method for diagnosis in the case of uniparental disomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Disorders involving imprinted regions:

A
  • Prader willi
  • Angelman
  • Beckwith-Wiedemann (Foetal overgrowth) 11
17
Q

How do epigenetic mechanisms mediate dosage compensation?

A
  • Dosage compensation: Random silencing of one of X chromosomes (except in kangaroos -> paternal always silenced)
  • One of the chromosomes is silenced by lncRNA (Xist)
  • Initially, both chromosomes express unstable Xist RNA -> stochastic choice of one to express Tsix first (antisense) -> degradation of Xist
  • On other chromosome, Xist binds to Xic and coats whole chromosome -> recruitment of factors to sequester as inactive heterochromatin -> Barr body
18
Q

How may X-inactivation vary in effect for carriers of X-linked disease:

A
  • Half of cells will lack expression of normal gene; effects depend on nature of gene product and extent/localisation of X-inactivation
  • Genes for secreted protein (e.g. blood clotting factor) unlikely to have much effect
  • Cell autonomous requirement (e.g. Dystrophin) tissues may be partially effected
  • Required for cell survival -> non-random X-inactivation (e.g. X-linked SCID)
19
Q

+ Why might a PWS patient display especially fair skin

A
  • OCA2 gene is next to region associated with the gene
  • If the deletion encompasses this, it will lose OCA2 expression
  • OCA2 is involved in pigmentation